Please login to the form below

Not currently logged in
Email:
Password:

apceth Biopharma appoints Dusan Kosijer as CFO

He joins the cell therapy company from Accovion GmbH

Dusan KosijerContract development and manufacturing organisation (CDMO) apceth Biopharma has promoted Dusan Kosijer to chief financial officer (CFO), a role that will see him further progress the firm’s business and executive strategy.

He joined Munich-based cell therapy-focused company in 2016 and was initially responsible for the company’s finance strategy and operations and the leadership of the accountant and purchasing team.

He said: “I am excited and honoured to be able to contribute to the company that operates successfully for almost 10 years in the fast-moving field of cell and gene therapy.

“We will continue to be relentless in our efforts to be the best and most reliable CDMO partner for the growing number of our renowned international clients.

“In parallel, apceth’s pipeline has recently entered a very thrilling phase, encouraging us to accelerate further the development of our first-in-class, first-in-man cell-based gene therapies.”

Kosijer has 14 years’ experience in corporate finance and pharmaceutical contract service businesses including Accovion GmbH - a European clinical research organisation now owned by Clinipace - where he was CFO.

Christine Guenther, CEO of apceth, said: “With Dusan’s longstanding background as a finance executive in the pharmaceutical contract services sector, Dusan will play a major role in further strengthening our successful track record as one of the leading CDMOs for complex cell and gene therapy products.

“Moreover, Dusan’s experience will strongly promote our dynamic innovative strategy behind apceth’s unique proprietary pipeline of genetically modified stem cell therapies.”

2nd June 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...